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There is an urgent need to develop new vaccines against highly pathogenic PRRS virus (HP-PRRSV)
variant in China. The actual use of each codon pairs is more or less frequent than that of the statistical
prediction and codon pair bias (CPB) usage affects gene translation. We “shufﬂed” the existing codons in
HP-PRRSV genes GP5, M, nsp2 and nsp9, so that the CPB of these genes could be more negative. De-
optimization of nsp9, the RNA-dependent RNA polymerase, signiﬁcantly decreased PRRSV replication in
porcine alveolar macrophages (PAMs). In vitro study showed that HV-nsp9min and HV-nsp29min were
remarkably attenuated in PAMs, and inoculation of pigs with 2 mln105.0 TCID50/ml of HV-nsp9
min or HV-
nsp29min did not cause PRRS. Importantly, pigs immunized with HV-nsp29min were fully protected
against different HP-PRRSV strains' lethal challenges. Our results imply that the CPB de-optimized HV-
nsp29min has the potential to be used as a live vaccine candidate against HP-PRRSV.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is one of
the most important diseases in the swine industry (Neumann
et al., 2005; Nieuwenhuis et al., 2012; Tian et al., 2007). It is
estimated that the losses associated with PRRS are approximately
$664 million per year in the United States alone (Neumann et al.,
2005). Most recently, there have been devastating outbreaks of
atypical PRRS in China and neighboring countries with a mortality
of 20 to 100% (Li et al., 2007; Zhou et al., 2008), which is caused by
a highly pathogenic PRRSV (HP-PRRSV) variant with an unique
molecular hallmark, namely a discontinuous deletion of 30 amino
acids in nonstructural protein 2 (nsp2). Currently, vaccination is
generally used to control atypical PRRS. However, the available
vaccines for HP-PRRSV are known to have drawbacks.
The etiological agent, PRRS virus (PRRSV), is a 15.4 kb
positive-sense RNA virus belonging to the family Arteriviridae,
the order Nidovirales (Gorbalenya et al., 2006). Comparative
genome sequence analysis has revealed that PRRSV has two
distinct genotypes, type 1 (European type) and type 2 (North
American type) (Benﬁeld et al., 1992; Nelsen et al., 1999). The
PRRSV genome consists of at least 10 overlapping open reading
frames (ORFs): ORFs 1a, 1b, 2a, 2b, 3, 4, 5a, 5, 6, 7 (Fang and Snijder,
2010; Firth et al., 2011; Johnson et al., 2011; Li et al., 2014; Oh and
Lee, 2012; Snijder and Meulenberg, 1998). ORF1a and ORF1b
encode replicative enzymes (Fang and Snijder, 2010), of which
nsp2 is the largest PRRSV protein and its central region is highly
variable with deletions and insertions (Fang et al., 2004; Kim et al.,
2010; Yoshii et al., 2008). The key enzymes for PRRSV RNA
synthesis are encoded in ORF1b, in particular the viral RNA-
dependent RNA polymerase (RdRp, nsp9), which is essential for
both genome replication and the synthesis of a nested set of
subgenomic (sg) mRNAs (Fang and Snijder, 2010). The GP5 and M
proteins, which are encoded by ORF5 and ORF6, respectively, are
the major structural proteins of PRRSV. It has been shown that one
of the major virulence determinants of PRRSV is located in GP5
(Kwon et al., 2008). As a non-glycosylated membrane protein, M is
closely associated with the function of GP5 and likely plays a key
role in virus assembly and budding.
The utilization of codon pair in protein coding sequences is
highly biased. Some pairs of codons are overrepresented, while
other pairs are underrepresented compared to the frequency
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expected from the usage of the individual codons of these pairs.
This phenomenon is termed as codon pair bias (CPB) (Gutman and
Hatﬁeld, 1989). Codon-pair bias has been found in every species
examined, and it can be quantiﬁed statistically (Moura et al.,
2007). Although it is not clear how codon pair preference is
formed (Buchan et al., 2006), the codon pair usage in an open
reading frame can inﬂuence the gene expression (Irwin et al.,
1995). It has been shown that synthesizing novel poliovirus and
inﬂuenza virus to contain underrepresented codon pairs while
exactly preserve the codon usage and amino acid sequence, can
dramatically attenuate the virus (Coleman et al., 2008, 2011;
Mueller et al., 2010; Yang et al., 2013). Recently, a report showed
that deoptimization of the major envelope GP5 gene attenuated
PRRSV (Ni et al., 2014).
To attenuate the HP-PRRSV strain HV, we redesigned large
parts of the coding regions of nsp2, nsp9, GP5 and M using rare
codon pairs by a speciﬁc de-optimization computer program
(Coleman et al., 2008). The program can rearrange synonymous
codons to yield rare codon pairs while not altering amino acid
sequence. Using chemical synthesis and reverse genetics we
constructed and rescued the recombinant HP-PRRSV virus HV-
nsp2min, HV-nsp9min, and HV-nsp29min. To be compared with their
parental strain HV, the recombinant viruses, especially HV-
nsp9min and HV-nsp29min replicated signiﬁcantly slower in vitro.
Most importantly, HV-nsp9min and HV-nsp29min were attenuated
in vivo and pigs vaccinated with HV-nsp29min were completely
protected from the lethal challenge with HP-PRRSV strains.
Results
The CPB in pig genome and construction of codon pair de-optimized
highly pathogenic PRRS virus
To attenuate the highly pathogenic PRRS virus HV strain by de-
optimization of the virus gene codon pair usage, we ﬁrst analyzed the
codon pair usage in the pig genome using the algorithm described
before (Coleman et al., 2008). Our analysis revealed that there was a
normal distribution between 0.2 to 0.3 for the CPB value of the pig
genes (Fig. 1). We then re-coded part coding regions for HV nsp2,
nsp9, GP5, and M genes using codon pairs which are under-
represented relative to the pig genome through shufﬂing the synon-
ymous codons without altering amino acid sequence. This resulted in
dozens or even hundreds of silent mutations (Table 1), and the CPB
values of the re-coded gene sequences were much lower than that of
normal pig genes (from 0.04472 to 0.40141 for GP5, 0.04297 to
0.40440 for M, from 0.03984 to 0.40700 for nsp2, and
0.00548 to 0.20000 or 0.40210 for nsp9) (Fig. 1 and Table 1).
The characteristics of the recoded gene segments and the changes of
their codon pair bias are summarized in Table 1.
To generate HV virus carrying the de-optimized gene segments,
we synthesized and incorporated the rearranged segments into
the full-length infectious cDNA construct of HV virus, and the
resulted plasmids were then transfected into 293FT cells. At 48 h
after transfection, cell culture supernatants were detected for
viable virus. Only HV with de-optimized nsp2 (designated as
HV-nsp2min) and HV with de-optimized nsp9 (CPB¼0.2) (desig-
nated as HV-nsp9min 0.2) yielded viable viruses (Fig. S1), while
the other three constructs did not produce any viable virus even
after three blind passages of the supernatants from transfected
cells. In order to get additional effects of the codon pair de-
optimization, we constructed HV-nsp29min plasmid with the de-
optimized nsp2 and de-optimized nsp9 (CPB¼0.2), and yielded
the de-optimized recombinant virus HV-nsp29min (Fig. S1). For
convenience, the virus HV-nsp9min 0.2 was abbreviated as HV-
nsp9min in the following studies.
Decreased ﬁtness of the codon pair de-optimized recombinant virus
in PAMs
To evaluate and compare the in vitro growth characteristics
between the recombinant virus HV-nsp2min, HV-nsp9min, HV-
nsp29min, and their parental virus HV, we examined their growth
kinetics in PAMs infected with an moi of 0.01. These de-optimized
viruses did not replicate as well as the wild-type HV (HV-wt). As
shown in Fig. 2A, there were hardly any living PAMs existed at 84 h
post-infection (hpi) with wild-type HV. However, there was no
obvious cytopathic effect observed in PAMs infected with either
HV-nsp9min or HV-nsp29min (Fig. 2A). The cytopathic effect
induced by the mutant virus HV-nsp2min was only slightly reduced
with respect to the wild-type HV (Fig. 2A). These mutated viruses
had similar growth curves with the wild-type HV, but they grew
much slower than the wild-type HV, and the titers of the de-
optimized viruses were lower compared to the wild-type HV at all
the time points examined during the replication (Fig. 2B). The titer
of HV-nsp2min at 84 hpi was decreased 4 folds compared to wild-
type HV, whereas the titer of HV-nsp9min at 84 hpi was much
lower by orders of magnitude, up to a factor of 1659. The
recombinant virus HV-nsp29min containing both nsp2min and
nsp9min replicated as much slowly as HV-nsp9min, suggesting that
de-optimization of PRRSV RNA-dependent RNA polymerase nsp9
has much severer effect on virus replication. These results corre-
sponded well with nsp2, nsp9, and GP5 protein and mRNA
expression levels analyzed by western blot (Fig. 2C) and RT-PCR
(Fig. 2D). Previous studies had hypothesized that attenuation of
virus through codon pair bias maybe result from the down-
regulation of protein synthesis (Coleman et al., 2011). We therefore
analyzed the expression of the wild-type and mutated nsp2 and
nsp9 genes cloned into pCMV-myc vector in porcine cell line CRL-
2843 using western blot. As shown in Fig. 2E, protein levels of both
nsp2min and nsp9min were signiﬁcantly down-regulated compared
to their parental wild-type genes. However, the mRNA expressions
of the mutated genes were even slightly higher when compared to
their parental wilt-type genes (Fig. 2F). Collectively, these results
suggest that codon pair de-optimization of viral genes decreases
their protein expressions, leading to the defect in replicative
capacity of the mutational viruses relative to their parental virus.
HV-nsp29min and HV-nsp9min was attenuated in pigs
Given that HV-nsp29min was highly attenuated in PAMs, we next
investigated its growth phenotype and pathogenesis in pigs to examine
whether it was also attenuated in vivo. Two groups of 4-week-old
healthy conventional pigs were inoculated with either wild-type HV
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Fig. 1. Calculated codon pair bias (CPB) score for all 14,724 swine genes. Each dot
represents the calculated CPB score of a gene plotted against its amino acid length.
Underrepresented codon pairs yield negative scores. The CPB of various PRRSV
gene segments are indicated by arrows.
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(5 pigs) or HV-nsp29min (8 pigs) intranasally with a dose of 2 ml105
TCID50/ml (To get higher virus titer for HV-nsp29min, HV-nsp29min
virus was concentrated by ultra-centrifugation), and the pigs were
monitored for disease symptoms continuously for 34 days. Pigs
infected with the wild-type HV strain quickly developed PRRS disease
including coughing, dyspnoea, anorexia, chemosis, shivering, lameness
and skin cyanopathy. High body temperatures (440 1C) could be
detected as early as 4 days post-inoculation (p.i.), and remained higher
than 40.5 1C from then (Fig. 3A). All 5 pigs died within 12 days p.i.
(Fig. 3B). However, the de-optimized virus HV-nsp29min only induced
transient elevated body temperatures, which did not exceed 39.5 1C
during 8–14 days p.i., and then fell into normal temperature range
(Fig. 3A). All pigs in HV-nsp29min inoculated group remained healthy
and did not show clinical symptoms (Fig. 3B). Serum samples from pigs
infected with the recombinant virus HV-nsp29min had signiﬁcantly
lower viral load than those from pigs infected with the wild-type HV at
all times detected, although the two viruses had similar growth kinetics
in vivo (Fig. 3C). At 4 days p.i., the titers of HV in serum samples quickly
increased to 106 TCID50/ml when less than 103 TCID50/ml of HV-
nsp29min could be detected. The wild-type HV achieved maximum
titers at around 12 days p.i., while the variant HV-nsp29min achieved
maximum titers at about 14 days p.i. However, there was an 10,000-
fold difference in the titers between the two viruses. The peak titer of
wild-type HV was about 107.4 TCID50/ml, whereas for HV-nsp29min, the
peak was only 103.4 TCID50/ml. Moreover, at 34 days p.i., HV-nsp29min
was eventually not detectable. To further determine the replicative
capacity and pathogenicity of HV-nsp29min in vivo, the pigs infected
with wild-type HV were necropsied when they were dying while 3 of
the 8 pigs inoculated with HV-nsp29min were euthanized at two weeks
p.i. Multiple tissues were collected for virus RNA quantiﬁcation and
histopathological analysis. Quantitative RT-PCR revealed that pigs
infected with HV-nsp29min had signiﬁcantly lower viral RNA loads in
Table 1
Characteristics of deoptimized PRRSV genome segments
Gene Coding regiona Deoptimized coding regionb Wildtype segment deoptimized segment Number of silent mutations Mutant virus viability
CPBc CpGd UpAe CPBc CpGd UpAe
GP5 13,698–14,300 13,698–14249 0.04 0.72 0.64 0.40 1.28 0.86 58 
M 14,285–14,809 14,285–14659 0.04 0.76 0.8 0.40 1.20 1.01 45 
nsp2 1336–4188 1474–2055 0.03 0.65 0.54 0.41 1.06 1.00 95 þ
nsp9 7474–9527 7683–9527 0.01 0.72 0.75 0.20 0.99 0.91 89 þ
0.40 1.28 1.13 232 
a Nucleotide position corresponding to PRRSV HV strain (GenBank accession no: JX317648)
b Nucleotide position within the HV gene segment that underwent the codon pair deoptimization algorithm.
c Codon-pair bias (CPB) of the corresponding sequence.
d Ratio of observed dinucleotide frequency to that expected based on mononucleotide composition i.e. f(CpG)/f(C)nf(G).
e Ratio of observed dinucleotide frequency to that expected based on mononucleotide composition i.e. f(UpA)/f(U)nf(A).
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Fig. 2. Recombinant PRRS virus HV-nsp9min and HV-nsp29min grow signiﬁcantly slower than their parental wild-type HP-PRRSV HV in-vitro. PAMs were infected with of
either wild-type HP-PRRSV HV, or recombinant PRRS virus HV-nsp2min, HV-nsp9min or HV-nsp29min at an MOI of 0.01. (A) Representative images of cytopathic effects
induced by PRRSV at 84 hpi. (B) Supernatants were collected at indicated times and titrated for virus using TCID50 method. (C and D) PAMs were infected with HV-wt, HV-
nsp2min, or HV-nsp9min at a multiplicity of infection (MOI) of 0.01. At 84 h post-infection, cell lysates were subjected for Western blot to examine the levels of nsp2, nsp9, GP5
and β-actin (C), and total RNAs were extracted from cells and qPCR was performed for analyzing the expression of nsp2, nsp9 and GP5 (D). (E) Analysis of nsp2 and nsp9
protein expression in transfected cells. CRL2843 cells were transfected with 200 ng pCMV-nsp2-wt, pCMV-nsp2min, pCMV-nsp9-wt, pCMV-nsp9min0.2 or pCMV-nsp9min0.4
individually, and Western blot (WB) analysis of proteins extracted from whole cell lysates was carried out with myc or β-actin antibodies. β-actin was used to indicate equal
protein loading. (F) RNA expression was analyzed by real-time PCR. The experiments were performed in triplicate, and differences were considered to be statistically
signiﬁcant if p o0.05. * and #, statistically signiﬁcant difference between each of the recombinant viruses and the wild-type virus at the time point indicated.
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different tissues (Fig. 3D) by a factor of orders of magnitude, from 3.5 to
5.6, including heart, liver, spleen, lung, kidney, tonsil, brain, thymus,
and some lymph nodes. Although the level of viral RNA loads in the
lung was higher compared to the other tissues in HV-nsp29min infected
pigs, it was still signiﬁcantly lower than that in the lungs of pigs
infected by wild-type HV by a factor up to 3.3 orders. Pathology
evaluation revealed that there were severe interstitial pneumonia,
thymic atrophy, enlarged lymph nodes, and blood spots on the kidney
in HV infected pigs. However, for HV-nsp29min infected pigs, no
obvious pathological damages were observed. Histological examina-
tions shown in Fig. 3E further conﬁrmed severe histopathologic
damages in all wild-type HV infected pigs including severe proliferative
interstitial pneumonia with alveolar septa thickened by lymphomono-
nuclear inﬁltration in the lung, and severe degrees of vasculitis
characterized by massive lymphomononuclear inﬁltration surrounding
perivascular cufﬁng in the brain. HV-infected pigs had thymic lesions of
cortical involution, causing a poor demarcation between the cortical
and medullary zones. However, no obvious histopathologic damages
other than mild interstitial pneumonia were observed in HV-nsp29min
infected pigs. We also infected pigs with HV-nsp9min and got similar
results as HV-nsp29min. Taken together, our results demonstrated that
the codon pair de-optimized virus HV-nsp9min and HV-nsp29min had
decreased replicative capacity, and thus were attenuated in pigs.
HV-nsp29min immunization protected pigs from HP-PRRSV strain
challenges
We next investigated whether vaccination with HV-nsp29min
could protect pigs from wild-type HP-PRRSV challenges. Groups of
four pigs were vaccinated with HV-nsp29min with a dose of 2 ml of
105 TCID50/ml, or mock vaccinated with RPMI 1640. Thirty-four
days after vaccination, the vaccinated pigs were challenged with
the wild-type HP-PRRSV strain HV (belonging to the 2006 to 2008
HP-PRRSV isolate subgroup) or another HP-PRRSV strain JX virus
(belonging to the 2009 to 2010 HP-PRRSV isolate subgroup) (Wang
et al., 2012) at a dose of 2 ml of 106 TCID50/ml. The mock
vaccinated pigs in the control group were challenged with the
wild-type HP-PRRSV strain HV. Viremia was cleared in each of the
pigs when challenge was performed at 34 days post-vaccination.
All pigs were necropsied at 14 days post-challenge.
As with the original infections, we monitored disease symp-
toms, the body temperature, and survival of the pigs for 14 days
after the challenge. Vaccination of the pigs with HV-nsp29min
could completely protect pigs from both wild-type HP-PRRSV
strain HV and another HP-PRRSV strain JX lethal challenges and
none of the pigs died (Fig. 4A) The vaccinated animals did not
show any clinical signs throughout the experiment, and their
body temperature remained in the normal range until the
experiment ﬁnished (Fig. 4B), while the body temperature of
mock vaccinated animals rapidly rose above 40 1C (Fig. 4B), and
all of them died within 14 days post-challenge (Fig. 4A). All the
mock vaccinated animals challenged with HP-PRRSV strain JX at
a dose of 2 ml of 106 TCID50/ml had similar symptoms and died
within 14 days. For pigs challenged with the homologous wild-
type strain HV, the serum viral load in the vaccinated pigs was
below102 TCID50/ml, which was signiﬁcantly reduced by more
than 10,000-fold compared to the mock vaccinated pigs at 4 and
8 dpc (Fig. 4C). For pigs challenged with the other HP-PRRSV
strain JX, the reduction of the serum viral loads were also more
than 10,000-fold compared to that in the mock vaccinated pigs
at 4 and 8 dpc, similar to that in pigs challenged with the
homologous wild-type HV strain (Fig. 4C). The viral RNA loads in
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Fig. 3. HV-nsp29min and HV-nsp9minwas attenuated in vivo. Pigs were intranasally inoculated with HV, HV-nsp29min or HV-nsp9min at a dose of 2105 TCID50. (A) Rectal
temperature was measured every two days for each group of pigs (n¼5) after virus infection. (B) Survival curves of pigs in each group. (C) Analysis of viral load in serum from
each group of pigs at indicated times post-infection. The limit of serum virus titers detection is indicated in dashed line. (D) Virus RNA load analysis for tissues collected
when pigs were dying or necropsied two weeks post-infection. LN, lymph node. (E) Histological examination of tissues collected when pigs were dying or necropsied two
weeks post-infection. Differences were considered to be statistically signiﬁcant if po0.05.
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tissues from vaccinated pigs challenged with homologous wild-
type HP-PRRSV strain HV or another HP-PRRSV strain JX were
comparable, and both were numbers of orders decreased com-
pared to that in control group pigs, especially in the lung, which
is the primary target organ of PRRSV infection. The viral titers in
pigs vaccinated with HV-nsp9min were about 5–6 orders of
magnitude lower than that in control group (Fig. 4D). Histologi-
cal examination showed that there were limited pathological
changes in lungs of the vaccinated pigs, whereas there was
severe interstitial pneumonia in un-vaccinated pigs (Fig. 4E).
Collectively, our results indicated that vaccination of the pigs
with HV-nsp29min could completely protect the animals from
HP-PRRSV isolate lethal challenges.
Neutralization antibody and CD8þ T cell response induced by the HV-
nsp29min variant
Live attenuated vaccines in general depend on a limited, yet
safe, degree of replication within the host to stimulate the immune
system. Since HV-nsp29min had a reduced replicative capacity and
was attenuated in pigs, we also investigated whether the limited
replication of HV-nsp29min could elicit protective immune
response in pigs against HP-PRRSV.
To investigate if the protective immune response is induced by
HV-nsp29min, serum neutralization assay and intracellular IFN-γ
ﬂow cytometric analysis were performed. As shown in Fig. 5A, at
8 days post-vaccination, neutralization antibody against PRRSV
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was about 1:2, and the titers of neutralization antibody increased
along with the time. At 34 days post-vaccination when challenge
was performed, the titers increased to about 1:16. IFN-γ is
considered to be a key cytokine in CD8þ T cell response, and
serves as an indicator for the cell mediated responses. Therefore,
we examined the levels of IFN-γ in CD8þ T cells from immunized
pigs when stimulated with HP-PRRSV strains HV and JX in vitro. As
shown in Fig. 5B, vaccination with HV-nsp29min signiﬁcantly
induced IFN-γ expressing CD8þ T cells (from 0.82 to 4.28% for
HV and 0.75 to 3.75% for JX), suggesting that a signiﬁcant cell-
mediated immune response against HP-PRRSV is induced by HV-
nsp29min vaccination. Collectively, these results indicated that the
attenuated HV-nsp29min possessed the ability to elicit decent
levels of neutralization antibody and CD8þ T cell responses against
HP-PRRSV infection.
Discussion
It has been known since 1989 that codon pair usage is biased
(Gutman and Hatﬁeld, 1989) and this phenomenon has previously
been studied primarily by informatics (Fedorov et al., 2002; Moura
et al., 2007). Coleman et al. reported that recoding poliovirus and
inﬂuenza virus with underrepresented codon pairs relative to
human genome caused poor translation and induced attenuation
in poliovirus and inﬂuenza virus (Coleman et al., 2008; Mueller
et al., 2010; Yang et al., 2013). Here, we successfully attenuated HP-
PRRSV through recoding virus nsp2 and nsp9 genes with under-
represented codon pairs relative to pig genome, while encoding
precisely the same amino acid sequences as wild-type virus,
thereby generating viral variants HV-nsp2min, HV-nsp9min, and
HV-nsp29min. And importantly, our data showed that HV-nsp9min
and HV-nsp29min were signiﬁcantly attenuated both in vitro and
in vivo, and pigs vaccinated with HV-nsp29min were protected
from HP-PRRSV strain lethal challenges.
Atypical PRRS caused by HP-PRRSV is a devastating disease for
swine industry in China and Southeast Asia. To date, three
empirical attenuated vaccines speciﬁc for HP-PRRSV are commer-
cialized in China, including JXA1-R, HuN4-F112 and TJM-F92. All of
these vaccines were obtained by passaging virulent PRRSV isolates
on the African green monkey kidney epithelial cell line Marc-145
(Han et al., 2009; Leng et al., 2012; Tian et al., 2009; Yu et al.,
2012). Disadvantages of current PRRSV MLVs include that they
have the risk of reversion to virulence, as well as that pigs
vaccinated with MLVs cannot be distinguished from those
naturally-infected with ﬁeld strains of PRRSV. The gene stability
of live attenuated virus is critical as they could infect and replicate
in the host, and small chance of the attenuated vaccine strain's
reversion to virulence may result in virus spreading caused by
vaccine inoculation. Hence, the use of live vaccines with PRRSV
strains prone to mutations has raised concern about safety,
especially since a vaccination program led to an epidemic of
American type 2 PRRSV in the previously unaffected Danish pig
population as a result of reversion to virulence of the vaccine
strain (Nielsen et al., 2001). In the present study, the attenuation
resulted from hundreds of nucleotide changes across the viral
genome, therefore reversion of the de-optimized variant to a
virulent form is unlikely, and also the attenuated virus can be
easily distinguished from the wild-type virus by PCR. More
importantly, co-infection of the vaccine recipient with a naturally
circulating wild-type virus could lead to RNA recombination
between PRRSV isolates (van Vugt et al., 2001; Yuan et al., 1999).
But this is unlikely to produce variants more virulent than the co-
infecting virus when the attenuated HV-nsp9min or HV-nsp29min is
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used, because the de-optimized segments of the vaccine strain
could only “attenuate” any such isolate.
The precise mechanism by which underrepresented codon
pairs cause attenuation is still unknown. It has been noticed that
introducing the unfavorable codon pairs also increases the number
of CpG or UpA nucleotide pairs present in the RNA of the virus
(Tulloch et al., 2014). It has long been known that genomes of RNA
viruses have low CpG and UpA dinucleotide frequencies (Rima and
McFerran, 1997; Rothberg and Wimmer, 1981), as do mammalian
coding regions generally (Alff-Steinberger, 1987), a phenomenon
which must be advantageous for viruses. Indeed, previous studies
have revealed that echovirus 7 with increased frequencies of CpG
and UpA show impaired replication kinetics and higher RNA/
infectivity ratios compared with wild-type virus. Remarkably,
mutants with CpGs and UpAs removed showed enhanced replica-
tion and larger plaques, and rapidly outcompeted wild-type virus
on co-infections (Atkinson et al., 2014). If the CpG or UpA content
is raised in the poliovirus polyprotein encoded with synonymous
rare CpG- and UpA-rich codons, the resulting variants are either
debilitated in growth (Burns et al., 2009; Atkinson et al., 2014) or
nonviable (Mueller et al., 2006). In our studies, we found that the
recoded segments within the GP5min, Mmin, nsp2min and nsp9min
genomes also present with an increased frequency of CpG and UpA
dinucleotides (Table 1). It has been proposed that increased CpG
may activate the innate immune response in some tissue culture
cells, thereby reducing viral replication (Burns et al., 2009;
Atkinson et al., 2014). Further investigation is needed to conﬁrm
whether the increased CpG activates innate immune response in
PAMs. Nevertheless, despite the underpresented codon pairs and
increased CpG and UpA frequencies within nsp2min, the recombi-
nant virus HV-nsp2min did not show obvious replication default,
implying that other factors, such as synthesis of the polyprotein,
its processing, misfolding, stability and/or parameters that have
yet to be investigated may also be related to the attenuation of the
codon pair deoptimized recombinant virus.
The protective immune response in pigs infected with wild-
type PRRSV is unusual due to a weak and delayed production of
neutralizing antibodies (NA) as well as a weak and slow gradual
development of a cell-mediated immune response (CMI) (Darwich
et al., 2010). In the present study, NA was about 1:2 at 8 day post-
immunization, and its titer was up to 1:16 at 24 day post-
vaccination. It was reported that pigs with a serum NA titer of
1:8 did not develop viremia (Lopez and Osorio, 2004; Osorio et al.,
2002), suggesting that a vaccine capable of inducing NA titres of
1/8 or higher should prevent clinical disease and be a key tool in
eradication of PRRSV. And it is true that in the present study,
PRRSV was undetectable in serum at 34 days post-infection. In a
recently published paper (Galliher-Beckley et al., 2015), the
authors showed that pigs vaccinated with JXA1-R, a commercial
vaccine modiﬁed from a HP-PRRSV strain, produced measurable
titers of neutralizing antibody against JXA1-R (412), and HV-
PRRSV (HP-PRRSV strain) (48), and NADC-20 (the most virulent
strains circulating in North America) (44) 28 days post-vaccina-
tion, and were protected from the challenge with DADC-20. In
addition, to assess PRRSV speciﬁc T-cell response in pigs, we
analyzed the IFN-γ positive CD8þ T cells at 34 days post-
infection. Recall response showed that about 4.28% and 3.75% of
CD8þ T cells were IFN-γ positive after being re-stimulated with
homologous HV and another HP-PRRSV JX isolate, respectively,
suggesting that effective cell-mediated immune response was also
induced. In the process of de-optimizing virus codon pair bias, the
amino acid sequence of viral gene is precisely conserved. There-
fore, vaccines produced in this way express the entire wild-type
repertoire of antigenic sites and would have the maximum chance
to induce both cellular and humoral immunity against all epitopes.
As the high gene homology shared among the different HP-PRRSV
strains, the attenuated virus variant could provide pigs with
complete protection against subsequent both HP-PRRSV lethal
challenges. The possible reasons for HV-nsp9min and HV-
nsp29min to be highly attenuated in vivo could be that 1) HV-
nsp9min and HV-nsp29min replicate much slower in porcine
macrophages, and therefore HV-nsp9min and HV-nsp29min infec-
tions could not cause much damage to macrophages, and subse-
quently induce high quality innate immune responses; 2) HV-
nsp9min and HV-nsp29min infection does not cause pathologic
effects on thymus, which is the site for T cell development, and
other tissues and organs such as bone marrow (data not shown).
Thus, immunization with HV-nsp29min infection induced relatively
high quality immune response and protected pigs from lethal
challenge with either homologous HP-PRRSV isolate or different
isolate. However, further investigation is needed to study the
underlying mechanisms for the attenuation.
Taken together, the synthesized codon pair de-optimized
PRRSV HV-nsp9min and HV-nsp29min were signiﬁcantly attenuated
and had potential to be used as vaccine candidates against HP-
PRRSV. Our results further ascertain that the strategy “de-optimi-
zation of codon pair bias to attenuate virus” pioneered by Coleman
et al. (2008) could be used to make modiﬁed live vaccines.
Materials and methods
Cells and viruses
Porcine alveolar macrophages (PAMs) were obtained by post-
mortem lung lavage of 8-week-old speciﬁc pathogen free (SPF)
pigs, and maintained in RPMI 1640 supplemented with 10% FBS
and penicillin/streptomycin. CRL-2843 (also referred as CD4/21)
cells, a porcine alveolar macrophage cell line, were maintained in
RPMI 1640 medium supplemented with 10% FBS and penicillin–
streptomycin.
The HP-PRRSV strain HV (GenBank accession no: JX317648) and
JX (GenBank accession no: JX317649), were propagated in PAMs.
Virus preparations were titrated on PAMs and then stored at
80 1C. The full length infectious cDNA clone of HV in eukaryotic
expression vector pcDNA3.1 (þ) was constructed and kept by our
lab (data not published).
Calculation of codon pair bias (CPB) in pig genome and design of
codon pair de-optimized PRRS virus
Based on the previous studies (Coleman et al., 2008), the CPB
for an entire open reading frame has been deﬁned as the
arithmetic mean of the individual codon pair scores (CPS). The
CPS of each codon pair is the natural log of the ratio of the
observed over the expected number of occurrences over all coding
regions in the genome. We calculated the CPS value for each of the
3721 codon pairs in pig genome as described before (Coleman
et al., 2008), and the results could be found in Supplementary
Table 1. A positive CPS means that the given codon pair is
statistically over-represented, while a negative CPS value signiﬁes
that the pair is statistically under-represented in the pig genome.
We then analyzed the CPB for 16,174 pig genes (download from
NCBI, in November 2011), and the calculated results were shown
in Fig. 1A positive CPB indicates a prevalent use of overrepresented
codon pairs, while a negative CPB represents the predominant use
of underrepresented codon pairs. The CPBs of part of open reading
frames of nsp2, nsp9, GP5 and M, corresponding to nucleotides
1474 to 2055, 7683 to 9527, 13,698 to 14,249, and 14,285 to 14,659
of the viral genome, respectively, were calculated as above. We
then shufﬂed the existing codons among the corresponding gene
segment so that the CPB can be decreased. All of the codon
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changes were synonymous: that is, none of them introduces any
amino acid change. The CpG and UpA dinucleotide frequencies in
the manipulated sequences was performed using the program
Sequence Mutate in version 1.2 of the SSE package (Simmonds,
2012). The precise extent of recoded sequence for each target
segment and the resulting changes in codon-pair bias were
summarized in Table 1. The codon pair de-optimized gene
sequences were synthesized de novo chemically (Nanjing Gen-
Script, China), and appropriate restriction sites were included at
both terminals of the segments. Then, the codon pair de-optimized
segment was cloned into the full length cDNA clone of HV to
replace the respective wild-type counterpart sequence. We con-
structed recombinant HV cDNA clone and yielded HV-nsp2min,
HV-nsp9min, HV-GP5min, HV-Mmin as well as HV-nsp29min plas-
mids in pcDNA3.1 downstream of CMV T7 promoter.
In vitro transfection and rescue of recombinant viruses
To rescue the infectious codon pair de-optimized PRRS viruses
from the recombinant DNA-launched infectious clones, we trans-
fected the plasmids HV-nsp2min, HV-nsp9min, HV-GP5min, HV-
Mmin and HV-nsp29min directly into 293FT cells individually
(Wang et al., 2014). Cell culture supernatant obtained at 48 h
post-transfection was inoculated on primary cultured PAMs and
immunoﬂuorescence assay was performed for virus detection as
described previously (Fig. S1) (Gao et al., 2013). Brieﬂy, cells were
ﬁxed with cold methanol-acetone (1:1) for 10 min at 4 1C, washed
with phosphate-buffered saline (PBS), and then blocked with 5%
normal goat serum for 30 min at room temperature. After block-
ing, cells were stained with anti-PRRSV N protein monoclonal
antibody SDOW17 (1:10,000; Rural Technologies), or an isotype
control antibody for 60 min at room temperature. Cells were then
washed and incubated with FITC-conjugated goat anti-mouse IgG
(HþL) (1:2000, Jackson ImmunoResearch) for 60 min at 37 1C.
After three washes in PBS, cells were counter-stained with DAPI
and examined by ﬂuorescence microscopy. The rescued virus was
designated as HV-nsp2min, HV-nsp9min or HV-nsp29min.
Growth characterization of the recombinant virus in vitro
To analyze the growth characteristics of the recombinant virus
in vitro, one-step growth curves were obtained by infecting a
monolayer of PAMs with a given virus. Conﬂuent monolayers of
PAMs seeded in 6-well plates were infected with the wild-type
virus HV and three rescued recombinant viruses HV-nsp2min, HV-
nsp9min, and HV-nsp29min at an MOI of 0.01 for 2 h at 37 1C, and
then the viral inoculum was removed. Cells were then washed
3 times with PBS and incubated at 37 1C for 12, 24, 36, 48, 72, and
84 h. The titers of virus harvested at these time points were
determined on PAMs and quantiﬁed as 50% tissue culture infective
doses (TCID50). At 84 h post-infection, cell lysates were also
subjected for Western blot to examine the levels of nsp2, nsp9,
GP5 and β-actin, and total RNAs were extracted from cells and
qPCR was performed for analyzing the expression of nsp2, nsp9
and GP5. All in vitro experiments were performed in triplicate.
Analysis of wild-type and codon pair de-optimized nsp2, and nsp9 gene
expression in transfected cells using Western blot and real-time PCR
The cDNA sequences encoding wild-type and codon pair de-
optimized nsp2 and nsp9 were cloned into pCMV-N-myc vector. The
ORF1a/ORF1b ribosomal frame shift site was removed as described
before (Gao et al., 2013). Brieﬂy, nucleotides T-7600 and A-7602
were mutated to C, and a nucleotide C was inserted between A-7604
and C-7605. Primers were listed in Table 2. CRL2843 cells in 6-well
plates were transfected with 200 ng of each of the plasmids
encoding the wild-type and codon pair de-optimized nsp2 and
nsp9 genes. Cells were harvested with RIPA lysis buffer supplemen-
ted with protease inhibitors at 18 h post-transfection. The proteins
were resolved by SDS-PAGE, and analyzed by western blot with
antibodies against myc (1:1000, Santa Cruz Biotechnology) and β-
actin (1:5000; Sigma, St. Louis, MO) and HRP-conjugated secondary
antibodies (1:10,000, Santa Cruz Biotechnology). The antibodies
were visualized using the ECL reagent according to the manufac-
turer's instructions. RNA was also harvested for nsp2 and nsp9 gene
expression analysis using real-time PCR at 18 h post-transfection
(hpt). Real-time PCR was performed using primers speciﬁc for nsp2
and nsp20.4 mutant (forward 50CTCGTTTCCCATCTCCCTATT30, and
reverse 50ACGCCGAGAAGACCCAGA30), nsp9 and nsp90.2 mutant
(forward 50CTCGTGGTTGGGATAGCG30, and reverse 50GGACAAG
AAGAACGGTGGG30), and nsp90.4 mutant (forward 50GCCGAG
GCTACTAAAGAGGA30, and reverse 50GGTATGTCTCCGAACCGTGTA30).
Pathogenicity study of the recombinant virus HV-nsp29min and HV-
nsp9min in vivo
To determine and compare the virulence of recombinant virus
HV-nsp29min, HV-nsp9min and the parental virus in pigs, we
obtained 4-week-old healthy conventional Large White–Dutch
Landrace crossbred pigs from a pig farm that was negative for
PRRSV and PCV2 infections. All pigs were further conﬁrmed to be
PRRSV and PCV2 antibodies free by using commercial enzyme-
linked immunosorbent assay (ELISA) kits (Idexx Lab., and Inge-
nasa). PRRSV, classical swine fever virus (CSFV), PCV2, and
pseudorabies virus (PRV) were also conﬁrmed to be free using
PCR or RT-PCR. A total of 21 pigs were randomly divided into
3 groups, and each pig was infected by intranasal inoculation with
2 ml of 105 TCID50/ml of virus. The control group of 5 pigs was
inoculated with wild-type HP-PRRSV strain HV, and the other two
groups (8 pigs each) were inoculated with the codon pair de-
optimized virus HV-nsp29min and HV-nsp9min, respectively. The
animals were observed daily for clinical signs including coughing,
dyspnoea, anorexia, diarrhea, lameness, and shivering. Rectal
temperatures were measured every other day for 34 days post-
inoculation (dpi). Serum was collected at 0, 4, 8, 12, 17, 25 and 34
dpi for the detection of viral titer by quantitative RT-PCR, and
known amounts of serially diluted in-vitro transcript virus cDNA
were used to generate a standard curve for each plate run
(Zuckermann et al., 2007). Three pigs in each of the HV-
nsp29min and HV-nap9min infected groups were necropsied at 14
days post-inoculation, while the other ﬁve pigs were necropsied at
34 dpi when the experiment was ﬁnished. Pigs in the control
group experiencing severe disease symptoms were necropsied at
any time when they were dying. At necropsy, tissues were
collected from each pig for histological examination and for
quantiﬁcation of viral-RNA loads.
Challenge-and-protection study in pigs vaccinated with the
recombinant virus HV-nsp29min
For vaccination experiments, twelve pigs were randomly
divided into three groups (4 pigs/each group). Two groups of pigs
Table 2
Primers used for cloning nsp2 and nsp9 gene.
Primer Sequence (50–30)
Nsp2f GA AGATCT CTGCCGGAAAGAGAGCAAGGAAAAC
Nsp2r GG GGTACC CTACCCTGAAGGCTTGGAAATTTG
Nsp9 (7474–7614) f GTTGGCATATGGCCGCCAAGCTTTCC
Nsp9 (7474–7614) r GGCTAGCAGGTTGAGACACTGCTCCT
Nsp9 (7593–9526) f GCAGTGTCTCAACCTGCTAGCCGCCAGC
Nsp9 (7593–9526) r CCGGATCCTTACTCATGATTGGACCTGAGTTTTTCC
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were vaccinated with HV-nsp29min virus at a dose of 2 mln105
TCID50/ml intranasally, while pigs in the control group were mock
vaccinated with RPMI 1640. Serum samples were collected at 8, 16,
24 and 34 days post-vaccination (dpv) for the determination of the
neutralization antibody titers. Whole blood samples were also
collected for CD8þ T cell response analysis at 34 dpv. At 34 dpv,
the vaccinated pigs were then challenged intranasally with 2 ml of
106 TCID50/ml of either the HP-PRRSV HV strain or the HP-PRRSV
JX strain, while the control group was challenged with the HP-
PRRSV HV strain. Clinical signs were monitored daily as above and
rectal temperature was measured every other day for 14 days
post-challenge (dpc). Serum samples were collected at 4, 8 and 12
dpc for the detection of viral RNA by quantitative RT-PCR. At 14
dpc, all pigs were necropsied, and tissues were collected for
histological examination and viral-RNA load quantiﬁcation.
RNA extraction and real-time PCR
Total RNA was extracted using Trizol Reagent (Invitrogen) and
500 ng RNA was used for cDNA synthesis using M-MLV (Promega).
Real-time PCR was performed using speciﬁc primers for PRRSV N
protein gene (forward AATAACAACGGCAAGCAGCA, and reverse
GCACAGTATGATGCGTCGGC) and GP5 protein gene (forward
50CTCACCACCAGCCATTTCCT30, and reverse 50TGCAGTTCTTCG
CAAGCCTA30) on ABI viiA7 Real-Time PCR System using the Real-
Time SYBR master mix kit (TAKARA) following the manufacturer's
introductions. For each experiment, a standard curve was gener-
ated using serially diluted PRRSV standard of 100–107 TCID50/ml.
Serum neutralization assay
Serum neutralization assay was performed as described before
(Ostrowski et al., 2002). Brieﬂy, serial 2-fold dilutions of 56 1C
heat-inactivated serum samples were incubated with 100 TCID50
of HP-PRRSV HV strain in RPMI 1640 containing 10% FBS for
60 min at 37 1C. Then, the mixtures were added to PAMs in 96-
well plates which had been cultured for 24 h prior to use. After
incubation for another 24 h, immunoﬂuorescence assay for PRRSV
detection was performed. Neutralization titers were interpreted as
the reciprocal of the highest dilution that showed 90% reduction or
greater in the number of the ﬂuorescent foci.
Intracellular IFN-γ ﬂow cytometric analysis
Peripheral blood leukocytes were prepared as described pre-
viously (Graham et al., 2012) and stimulated with PRRSV antigen
(10 μg/ml) for 6 h at 37 1C. Brefeldin A (10 μg/ml, BD Bioscience)
was added to block cytokine release for a further 2 h. Then the
cells were stained with anti-CD8α-FITC or isotype control (AbD-
serotec) for 30 min at 4 1C. After washing, cells were ﬁxed with 4%
paraformaldehyde and permeabilized with 0.1% saponin, and then
stained with anti-IFN-γ-RPE or isotype control (AbDserotec) over-
night at 4 1C. Cells were washed and then analyzed by ﬂow
cytometry. Data were acquired using a FACS Calibur (BD
Bioscience) and analyzed using FlowJo software.
Statistical analysis
All experiments were performed with at least three indepen-
dent replicates. Results were analyzed using Student's t-test.
Differences were considered to be statistically signiﬁcant if the p
value was less than 0.05. The data were analyzed using GraphPad
Prism 5.0.
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